SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-030838
Filing Date
2022-08-25
Accepted
2022-08-25 09:29:30
Documents
13
Period of Report
2022-08-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10041231_8k.htm   iXBRL 8-K 27248
2 EXHIBIT 99.1 brhc10041231_ex99-1.htm EX-99.1 6691
  Complete submission text file 0001140361-22-030838.txt   171433

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cbio-20220825.xsd EX-101.SCH 3907
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20220825_lab.xml EX-101.LAB 22546
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20220825_pre.xml EX-101.PRE 16072
7 EXTRACTED XBRL INSTANCE DOCUMENT brhc10041231_8k_htm.xml XML 4058
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 221193639
SIC: 2834 Pharmaceutical Preparations